177 related articles for article (PubMed ID: 2353405)
1. Major new developments affecting treatment and prognosis in hypertension.
Gubner RS
Trans Assoc Life Insur Med Dir Am; 1990; 73():97-114. PubMed ID: 2353405
[TBL] [Abstract][Full Text] [Related]
2. The heart (ventricle and atrium) is the heart of hypertension, not blood pressure.
Gubner RS
Can J Cardiol; 1990 Oct; 6(8):367-72. PubMed ID: 2148501
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive therapy in diabetic patients.
Weidmann P; Boehlen LM; de Courten M; Ferrari P
J Hum Hypertens; 1992 Dec; 6 Suppl 2():S23-36. PubMed ID: 1289510
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
7. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
8. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
Klaus D
Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
[TBL] [Abstract][Full Text] [Related]
9. Treatment of left ventricular hypertrophy in hypertensive patients.
Tamargo J; Delpón E; Valenzuela C
Eur Heart J; 1993 Nov; 14 Suppl J():102-6. PubMed ID: 8281952
[TBL] [Abstract][Full Text] [Related]
10. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
11. Beyond blood pressure control. Effect of antihypertensive therapy on cardiovascular risk factors.
Maxwell MH
Am J Hypertens; 1988 Oct; 1(4 Pt 2):366S-371S. PubMed ID: 3056446
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment.
Novo S; Abrignani MG; Corda M; Strano A
Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619
[TBL] [Abstract][Full Text] [Related]
13. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
14. [Regression of left ventricular hypertrophy in hypertensive heart disease].
Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
[TBL] [Abstract][Full Text] [Related]
15. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
16. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive therapy in the nineties].
Weidmann P; Ferrari P
Schweiz Rundsch Med Prax; 1992 Feb; 81(7):188-98. PubMed ID: 1535954
[TBL] [Abstract][Full Text] [Related]
18. [Differential therapy of exercise hypertension].
Klaus D
Herz; 1987 Apr; 12(2):146-55. PubMed ID: 3583208
[TBL] [Abstract][Full Text] [Related]
19. Hypertensive heart disease--significance of left ventricular hypertrophy.
Schmieder RE
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
